The brain can direct the immune system to an unexpected degree, capable of detecting, ramping up and tamping down inflammation, shows a new study in mice from researchers at Columbia’s Zuckerman Institute.
Weeks after closing Bristol Myers deal, Karuna’s ex-CEO heads to Blackstone-backed Anthos
How does Bill Meury celebrate a $14 billion merger? With a new post at a Blackstone-founded biotech. Meury has been appointed CEO at Anthos Therapeutics,